Apoproteins: determinants of lipoprotein metabolism and indices of coronary risk.
作者信息
Thompson G
出版信息
Br Heart J. 1984 Jun;51(6):585-8. doi: 10.1136/hrt.51.6.585.
Abstract
摘要
相似文献
1
Apoproteins: determinants of lipoprotein metabolism and indices of coronary risk.载脂蛋白：脂蛋白代谢的决定因素及冠心病风险指标
Br Heart J. 1984 Jun;51(6):585-8. doi: 10.1136/hrt.51.6.585.
2
Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.单基因血脂异常：血浆脂蛋白代谢决定因素之窗
Am J Hum Genet. 2001 Dec;69(6):1161-77. doi: 10.1086/324647. Epub 2001 Oct 26.
3
Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).载脂蛋白E（在脂蛋白代谢及III型高脂蛋白血症病理生理学中的作用）
Ric Clin Lab. 1982 Jan-Mar;12(1):23-30.
4
Effects of antihypertensive drugs on plasma lipids.抗高血压药物对血脂的影响。
Am J Cardiol. 1987 Sep 18;60(9):24E-28E. doi: 10.1016/0002-9149(87)90538-8.
5
[Apolipoproteins - an important diagnostic indicator in the evaluation of coronary disease risk].
Pol Arch Med Wewn. 1980 Aug;64(2):161-6.
6
[Relation of serum lipids disorders and ischemic heart disease in diabetics].[糖尿病患者血脂紊乱与缺血性心脏病的关系]
Hokkaido Igaku Zasshi. 1989 Jul;64(4):406-10.
7
[Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra].[不同脂蛋白谱的缺血性心脏病患者血浆载脂蛋白A-1和B以及2种高密度脂蛋白亚类的载脂蛋白A-1]
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1983;6(1):83-9.
8
Effects of CS-514, a new inhibitor of HMG CoA reductase, on plasma lipids, lipoproteins and apoproteins in patients with primary hypercholesterolemia.
Horm Metab Res. 1986 Sep;18(9):654-5. doi: 10.1055/s-2007-1012398.
9
Genetics of coronary heart disease and its risk factors.
Prog Clin Biol Res. 1985;177:351-74.
10
Effect of pirozadil on lipids, lipoproteins and apolipoproteins in Japanese with type IIa hyperlipoproteinemia.
Arzneimittelforschung. 1987 Sep;37(9):1069-71.
引用本文的文献
1
Apolipoprotein B: novel indicator of elevated intraocular pressure.载脂蛋白B：眼压升高的新型指标。
Eye (Lond). 2015 Oct;29(10):1315-20. doi: 10.1038/eye.2015.37. Epub 2015 Mar 20.
2
Coronary artery bypass grafting and hyperlipidaemia.冠状动脉搭桥术与高脂血症
Br Heart J. 1985 Mar;53(3):237-9. doi: 10.1136/hrt.53.3.237.
3
Familial hypercholesterolaemia as an example of early diagnosis of coronary artery disease risk by DNA techniques.以家族性高胆固醇血症为例，说明通过DNA技术早期诊断冠状动脉疾病风险。
Br Heart J. 1986 Sep;56(3):201-5. doi: 10.1136/hrt.56.3.201.
4
High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease.冠状动脉疾病中高甘油三酯血症和载脂蛋白异常的高患病率。
Br Heart J. 1988 Nov;60(5):397-403. doi: 10.1136/hrt.60.5.397.
5
Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction.有或无既往心肌梗死的中年男性的血清载脂蛋白AI、B及脂蛋白
Br Heart J. 1986 Sep;56(3):206-12. doi: 10.1136/hrt.56.3.206.
6
Serum lipoproteins and apolipoproteins in young normocholesterolaemic, non-diabetic Indian men with myocardial infarction.患有心肌梗死的年轻血脂正常、非糖尿病印度男性的血清脂蛋白和载脂蛋白
Postgrad Med J. 1991 Feb;67(784):159-64. doi: 10.1136/pgmj.67.784.159.
本文引用的文献
1
Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease.作为临床决策指南的流行病学。甘油三酯与冠心病之间的关联。
N Engl J Med. 1980 Jun 19;302(25):1383-9. doi: 10.1056/NEJM198006193022503.
2
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure.通过简单沉淀法分离和定量人血浆高密度脂蛋白亚类
J Lipid Res. 1982 Nov;23(8):1206-23.
3
Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis.高载脂蛋白B血症与内源性高甘油三酯血症及动脉粥样硬化的关联。
Ann Intern Med. 1982 Dec;97(6):833-9. doi: 10.7326/0003-4819-97-6-833.
4
Familial dysbetalipoproteinemia. New aspects of pathogenesis and diagnosis.家族性异常β脂蛋白血症。发病机制与诊断的新进展。
Med Clin North Am. 1982 Mar;66(2):441-54. doi: 10.1016/s0025-7125(16)31429-8.
5
Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography.通过血管造影检查的男性患者中，血浆载脂蛋白B以及极低密度脂蛋白胆固醇、低密度脂蛋白胆固醇和高密度脂蛋白胆固醇作为冠状动脉疾病发生的风险因素。
Atherosclerosis. 1981 Jun;39(3):411-24. doi: 10.1016/0021-9150(81)90026-5.
6
Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].冠状动脉粥样硬化与高载脂蛋白血症的关联[人血浆低密度（β）脂蛋白中蛋白质增加但胆固醇水平正常]
Proc Natl Acad Sci U S A. 1980 Jan;77(1):604-8. doi: 10.1073/pnas.77.1.604.
7
Identification and DNA sequence of a human apolipoprotein E cDNA clone.人载脂蛋白E cDNA克隆的鉴定及DNA序列分析
J Biol Chem. 1982 Dec 25;257(24):14639-41.
8
Genetic polymorphism and plasma lipoproteins.基因多态性与血浆脂蛋白
Nature. 1983 Feb 24;301(5902):658. doi: 10.1038/301658a0.
9
Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.血管造影定义的冠状动脉疾病与血浆脂蛋白亚组分及载脂蛋白的关系。
Br Med J (Clin Res Ed). 1981 May 30;282(6278):1741-4. doi: 10.1136/bmj.282.6278.1741.
10
Workshop on apolipoprotein quantification.载脂蛋白定量研讨会
Arteriosclerosis. 1983 Sep-Oct;3(5):452-64. doi: 10.1161/01.atv.3.5.452.
Zotero 插件